Annual Net Income
-$48.82 M
-$15.80 M-47.86%
December 31, 2023
Summary
- As of March 5, 2025, ATNM annual net profit is -$48.82 million, with the most recent change of -$15.80 million (-47.86%) on December 31, 2023.
- During the last 3 years, ATNM annual net income has fallen by -$26.60 million (-119.75%).
- ATNM annual net income is now -2871747.06% below its all-time high of $1700.00, reached on December 31, 2010.
Performance
ATNM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$11.57 M
-$215.00 K-1.89%
September 30, 2024
Summary
- As of March 5, 2025, ATNM quarterly net profit is -$11.57 million, with the most recent change of -$215.00 thousand (-1.89%) on September 30, 2024.
- Over the past year, ATNM quarterly net income has stayed the same.
- ATNM quarterly net income is now -429.09% below its all-time high of $3.52 million, reached on June 30, 2014.
Performance
ATNM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$40.91 M
+$1.71 M+4.01%
September 30, 2024
Summary
- As of March 5, 2025, ATNM TTM net profit is -$40.91 million, with the most recent change of +$1.71 million (+4.01%) on September 30, 2024.
- Over the past year, ATNM TTM net income has stayed the same.
- ATNM TTM net income is now -620024.24% below its all-time high of $6600.00, reached on June 30, 2010.
Performance
ATNM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ATNM Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -47.9% | 0.0% | 0.0% |
| 3 y3 years | -119.8% | -80.1% | -76.8% |
| 5 y5 years | -106.4% | -75.3% | -86.8% |
ATNM Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -97.0% | at low | -125.5% | +23.8% | -66.4% | +18.4% |
| 5 y | 5-year | -122.9% | at low | -151.3% | +23.8% | -100.2% | +18.4% |
| alltime | all time | <-9999.0% | at low | -429.1% | +30.7% | <-9999.0% | +18.4% |
Actinium Pharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.57 M(+1.9%) | -$40.91 M(-4.0%) |
| Jun 2024 | - | -$11.35 M(+30.9%) | -$42.62 M(-8.2%) |
| Mar 2024 | - | -$8.67 M(-7.0%) | -$46.45 M(-4.8%) |
| Dec 2023 | -$48.82 M(+47.9%) | -$9.32 M(-29.8%) | -$48.82 M(-2.6%) |
| Sep 2023 | - | -$13.28 M(-12.5%) | -$50.14 M(+8.2%) |
| Jun 2023 | - | -$15.18 M(+37.5%) | -$46.34 M(+19.0%) |
| Mar 2023 | - | -$11.04 M(+3.7%) | -$38.92 M(+17.9%) |
| Dec 2022 | -$33.02 M(+33.3%) | -$10.65 M(+12.4%) | -$33.02 M(+8.7%) |
| Sep 2022 | - | -$9.47 M(+22.0%) | -$30.38 M(+11.2%) |
| Jun 2022 | - | -$7.77 M(+51.4%) | -$27.33 M(+11.2%) |
| Mar 2022 | - | -$5.13 M(-36.0%) | -$24.58 M(-0.8%) |
| Dec 2021 | -$24.77 M(+11.5%) | -$8.01 M(+24.7%) | -$24.77 M(+7.0%) |
| Sep 2021 | - | -$6.42 M(+27.9%) | -$23.14 M(+4.0%) |
| Jun 2021 | - | -$5.02 M(-5.6%) | -$22.26 M(+1.8%) |
| Mar 2021 | - | -$5.32 M(-16.6%) | -$21.86 M(-1.6%) |
| Dec 2020 | -$22.21 M(+1.4%) | -$6.38 M(+15.2%) | -$22.21 M(+8.7%) |
| Sep 2020 | - | -$5.54 M(+19.8%) | -$20.44 M(-4.9%) |
| Jun 2020 | - | -$4.63 M(-18.4%) | -$21.50 M(-1.8%) |
| Mar 2020 | - | -$5.67 M(+23.2%) | -$21.90 M(0.0%) |
| Dec 2019 | -$21.90 M(-7.4%) | -$4.60 M(-30.2%) | -$21.90 M(-7.3%) |
| Sep 2019 | - | -$6.60 M(+31.3%) | -$23.62 M(+1.9%) |
| Jun 2019 | - | -$5.03 M(-11.3%) | -$23.16 M(+0.7%) |
| Mar 2019 | - | -$5.67 M(-10.3%) | -$23.00 M(-2.8%) |
| Dec 2018 | -$23.65 M(-11.1%) | -$6.32 M(+2.8%) | -$23.65 M(+5.1%) |
| Sep 2018 | - | -$6.15 M(+26.4%) | -$22.50 M(-0.8%) |
| Jun 2018 | - | -$4.86 M(-23.1%) | -$22.67 M(-8.8%) |
| Mar 2018 | - | -$6.32 M(+22.5%) | -$24.86 M(-6.5%) |
| Dec 2017 | -$26.60 M(+9.4%) | -$5.16 M(-18.3%) | -$26.60 M(-5.4%) |
| Sep 2017 | - | -$6.32 M(-10.4%) | -$28.13 M(-1.0%) |
| Jun 2017 | - | -$7.05 M(-12.5%) | -$28.41 M(+1.5%) |
| Mar 2017 | - | -$8.06 M(+20.4%) | -$27.98 M(+15.0%) |
| Dec 2016 | -$24.32 M(+15.7%) | -$6.70 M(+1.5%) | -$24.32 M(+0.6%) |
| Sep 2016 | - | -$6.60 M(-0.4%) | -$24.17 M(+12.3%) |
| Jun 2016 | - | -$6.62 M(+50.4%) | -$21.51 M(-3.8%) |
| Mar 2016 | - | -$4.40 M(-32.7%) | -$22.35 M(+6.3%) |
| Dec 2015 | -$21.03 M | -$6.54 M(+65.7%) | -$21.03 M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | -$3.95 M(-47.1%) | -$19.91 M(-9.7%) |
| Jun 2015 | - | -$7.46 M(+142.7%) | -$22.04 M(+99.2%) |
| Mar 2015 | - | -$3.07 M(-43.3%) | -$11.06 M(-55.2%) |
| Dec 2014 | -$24.69 M(+129.1%) | -$5.43 M(-10.7%) | -$24.69 M(-1.8%) |
| Sep 2014 | - | -$6.08 M(-272.9%) | -$25.14 M(+22.7%) |
| Jun 2014 | - | $3.52 M(-121.0%) | -$20.49 M(-23.5%) |
| Mar 2014 | - | -$16.70 M(+184.0%) | -$26.78 M(+148.6%) |
| Dec 2013 | -$10.77 M(+28.9%) | -$5.88 M(+313.8%) | -$10.77 M(+38.6%) |
| Sep 2013 | - | -$1.42 M(-49.0%) | -$7.77 M(-17.0%) |
| Jun 2013 | - | -$2.78 M(+304.1%) | -$9.36 M(+15.0%) |
| Mar 2013 | - | -$689.00 K(-76.1%) | -$8.14 M(-2.6%) |
| Dec 2012 | -$8.36 M(+142.7%) | -$2.88 M(-4.5%) | -$8.36 M(-6.5%) |
| Sep 2012 | - | -$3.01 M(+92.8%) | -$8.94 M(+50.7%) |
| Jun 2012 | - | -$1.56 M(+71.9%) | -$5.93 M(+36.4%) |
| Mar 2012 | - | -$908.90 K(-73.7%) | -$4.35 M(+26.3%) |
| Dec 2011 | -$3.44 M(<-9900.0%) | -$3.46 M(>+9900.0%) | -$3.44 M(<-9900.0%) |
| Sep 2011 | - | -$3500.00(-117.1%) | $4500.00(-364.7%) |
| Jun 2011 | - | $20.50 K(-612.5%) | -$1700.00(-128.3%) |
| Mar 2011 | - | -$4000.00(-52.9%) | $6000.00(+252.9%) |
| Dec 2010 | $1700.00(-107.6%) | -$8500.00(-12.4%) | $1700.00(+142.9%) |
| Sep 2010 | - | -$9700.00(-134.4%) | $700.00(-89.4%) |
| Jun 2010 | - | $28.20 K(-439.8%) | $6600.00(-126.1%) |
| Mar 2010 | - | -$8300.00(-12.6%) | -$25.30 K(+13.5%) |
| Dec 2009 | -$22.30 K(-28.5%) | -$9500.00(+150.0%) | -$22.30 K(+9.3%) |
| Sep 2009 | - | -$3800.00(+2.7%) | -$20.40 K(+2.5%) |
| Jun 2009 | - | -$3700.00(-30.2%) | -$19.90 K(-22.6%) |
| Mar 2009 | - | -$5300.00(-30.3%) | -$25.70 K(-17.6%) |
| Dec 2008 | -$31.20 K(+28.4%) | -$7600.00(+130.3%) | -$31.20 K(-17.2%) |
| Sep 2008 | - | -$3300.00(-65.3%) | -$37.70 K(-7.6%) |
| Jun 2008 | - | -$9500.00(-12.0%) | -$40.80 K(+17.6%) |
| Mar 2008 | - | -$10.80 K(-23.4%) | -$34.70 K(+42.8%) |
| Dec 2007 | -$24.30 K(+32.1%) | -$14.10 K(+120.3%) | -$24.30 K(+30.6%) |
| Sep 2007 | - | -$6400.00(+88.2%) | -$18.60 K(-15.5%) |
| Jun 2007 | - | -$3400.00(+750.0%) | -$22.00 K(+18.3%) |
| Mar 2007 | - | -$400.00(-95.2%) | -$18.60 K(+2.2%) |
| Dec 2006 | -$18.40 K | -$8400.00(-14.3%) | -$18.20 K(+85.7%) |
| Sep 2006 | - | -$9800.00 | -$9800.00 |
FAQ
- What is Actinium Pharmaceuticals annual net profit?
- What is the all time high annual net income for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual net income year-on-year change?
- What is Actinium Pharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly net income year-on-year change?
- What is Actinium Pharmaceuticals TTM net profit?
- What is the all time high TTM net income for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals TTM net income year-on-year change?
What is Actinium Pharmaceuticals annual net profit?
The current annual net income of ATNM is -$48.82 M
What is the all time high annual net income for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual net profit is $1700.00
What is Actinium Pharmaceuticals annual net income year-on-year change?
Over the past year, ATNM annual net profit has changed by -$15.80 M (-47.86%)
What is Actinium Pharmaceuticals quarterly net profit?
The current quarterly net income of ATNM is -$11.57 M
What is the all time high quarterly net income for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly net profit is $3.52 M
What is Actinium Pharmaceuticals quarterly net income year-on-year change?
Over the past year, ATNM quarterly net profit has changed by $0.00 (0.00%)
What is Actinium Pharmaceuticals TTM net profit?
The current TTM net income of ATNM is -$40.91 M
What is the all time high TTM net income for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high TTM net profit is $6600.00
What is Actinium Pharmaceuticals TTM net income year-on-year change?
Over the past year, ATNM TTM net profit has changed by $0.00 (0.00%)